MENU
Showcases Stock ranks Forex

Atai Life Sciences N.V. (ATAI)
4.43  0.05 (1.14%) 08-08 16:00
Open: 4.5 Pre. Close: 4.38
High: 4.86 Low: 4.3914
Volume: 1,753,038 Market Cap: 712M
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD); RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia; DMX-1002, an oral formulation of ibogaine for treating opioid use disorder (OUD); GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment; and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD; EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder; RLS-01, a formulation of Salvinorin A for TRD; KUR-101, an oral formulation of deuterated mitragynine to treat OUD; and DMX-1001, an oral formulation of noribogaine for the treatment of OUD. The company was formerly known as Adripa Holding B.V. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 4.863 - 4.877 4.877 - 4.893
Low: 4.349 - 4.366 4.366 - 4.384
Close: 4.401 - 4.426 4.426 - 4.453
Stock Technical Analysis
Overall:     
Target: Six months: 5.68
One year: 6.63
Support: Support1: 4.03
Support2: 3.51
Resistance: Resistance1: 4.86
Resistance2: 5.68
Pivot: 4.01
Moving Averages: MA(5): 4.15
MA(20): 4.05
MA(100): 4.17
MA(250): 8.07
MACD: MACD(12,26): 0.07
Signal(12,26,9): 0.04
%K %D: %K(14,3): 71.72
%D(3): 61.24
RSI: RSI(14): 62.08
52-Week: High: 17.9
Low: 2.95
Change(%): -70.0
Average Vol(K): 3-Month: 824
10-Days: 953
Price, MAs and Bollinger Bands
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

[ ATAI ] has closed below upper band by 10.2%. Bollinger Bands are 0.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock chart
Stock News
Fri, 05 Aug 2022
Midday Report: ATAI Life N.V. (ATAI) Shares Up on August 5 - Equities News

Thu, 28 Jul 2022
7 Psychedelic Stocks to Watch - WTOP

Fri, 22 Jul 2022
New Regulations for Psychedelics? Here's What Investors Need to Know - Nasdaq

Mon, 18 Jul 2022
Should You Buy ATAI Life Sciences NV (ATAI) Stock Monday Morning? - InvestorsObserver

Thu, 14 Jul 2022
ATAI Life Sciences NV (ATAI) Stock: What Does the Chart Say Thursday? - InvestorsObserver

Tue, 12 Jul 2022
Cathie Wood Watch: Ark Buys Big Into Biotech - TheStreet

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M)
Shares Float (M) 160.73
% Held by Insiders 132380000.00
% Held by Institutions 9.41
Shares Short (K) 4380
Shares Short Prior Month (K)
Stock Financials
EPS -158690000.000
Book Value (p.s.)
Profit Margin
Operating Margin -32.00
Return on Assets (ttm) 13.9
Return on Equity (ttm) -37.5
Qtrly Rev. Growth 496000.0
Gross Profit (p.s.) 0.127
Sales Per Share 0.127
EBITDA (p.s.) -0.750
Qtrly Earnings Growth -1.40
Operating Cash Flow (M)
Levered Free Cash Flow (M) -70.71
Stock Valuation
PE Ratio
PEG Ratio
Price to Book value
Price to Sales 34.84
Price to Cash Flow
Stock Dividends
Dividend
Dividend Yield
Dividend Growth 5140000.000

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android